Brexit and the Healthcare Industry – Thematic Intelligence
All the vital news, analysis, and commentary curated by our industry experts.
Brexit and the Healthcare Industry Thematic Report Overview
It has been three years since the UK departed from the EU. Even though Brexit was feared to impact UK’s economic growth at that time, Great Britain had to simultaneously deal with additional challenges such as the COVID-19 pandemic, inflation, and the Russia-Ukraine war. While some believed that leaving the EU would bring opportunities for the UK and its healthcare sector, Brexit was also blamed for uncertainty, workforce shortages, and worsened economic performance.
Brexit is believed to have a greater damaging impact on the UK’s healthcare sector than inflation or the COVID-19 pandemic. Healthcare industry professionals indicated that their sentiment on the impact of Brexit on the healthcare sector has become more negative over the past three years. Most respondents did not believe that the UK remained an attractive destination for healthcare research and manufacturing following Brexit.
According to GlobalData’s The State of the Biopharmaceutical Industry 2023 report, Brexit was scored as a trend having a negative impact on the global biopharmaceutical industry in 2023 by the surveyed healthcare industry professionals. However, the proportion of the respondents giving a positive score to Brexit has increased since 2022.
In the Brexit and the healthcare industry thematic report, GlobalData examines the business environment, weighs the challenges and opportunities, and assesses the risks that the UK’s healthcare sector is continuing to face post-Brexit. The report also highlights the impact from global inflation and measures how the UK would have performed had it not decided to rupture its ties with the EU. The objectives of this report include benchmark factors that will impact healthcare, determine impact on research and manufacturing, track changes to corporate strategy, examine ongoing healthcare-related policies and initiatives, determine changes in respondents’ attitudes and perceptions, assess the impact of inflation, and capture physicians’ perception of Brexit.
Impact of Brexit on Healthcare
The UK is home to some of the top research universities in the world. Before Brexit, the UK was known as a global leader in pipeline development. Nevertheless, there was a slight decline in clinical trials that commenced in the UK after the initiation of Brexit. The lowest number of initiated clinical trials in the UK was seen in 2020.
Pharmaceutical supply chains, healthcare workforce, and healthcare system delivery were selected as the top areas that saw the most substantial decline after the UK’s departure from the EU. While some supply chain issues have been partially sorted, such as Windsor Framework ensuring the supply and access of medicines from the UK into NI, the weaker pound and more bureaucracy at the borders are impacting costs and slowing down the movement of medicines.
Impact of Brexit on Healthcare, by Various Aspects of the Healthcare sector
For more insights on the impact of Brexit in the healthcare industry, download a free report sample
Impact of Brexit on Research and Manufacturing
Regulatory implications of the UK leaving the EEA was the top factor impacting the UK healthcare industry post Brexit. The pharmaceutical industry is one of the most regulated and complex industries in the world, and the UK is not an exception. Healthcare industry professionals are concerned about the changes that any new regulations may bring.
According to respondents in GlobalData surveys conducted in 2018, 2019, and 2021, regulatory implications followed by drug supply chain disruptions were the two biggest challenges for the healthcare sector to face post Brexit.
Initiatives that Could Help the UK’s Healthcare Industry to Recover
Even though UK clinical trial activity has remained relatively consistent since the EU membership referendum result, the respondents believed that reducing barriers to collaborations between the UK and EU on clinical research and aligning closely to the EU’s medical devices and drug approval system would be the top two initiatives that could help the UK’s pharmaceutical industry to grow post-Brexit.
Like the 2021 findings, investing in emerging technologies such as artificial intelligence, speeding up the approval process for medical devices and medicines, and relaxing clinical trial regulations were among the most favored initiatives.
For more insights on the initiatives that could help the UK’s healthcare industry to recover post-Brexit, download a free report sample
The research source in this report is based on the opinions and expectations of 120 global healthcare industry professionals surveyed from February 9, 2023, to March 6, 2023, and 85 UK physicians surveyed from January 31, 2023 to March 8, 2023, to gauge Brexit impact on the healthcare industry. Objectives of this report include:
- Benchmark factors that will impact healthcare
- Determine impact on research and manufacturing
- Track changes to corporate strategy
- Examine ongoing healthcare-related policies and initiatives
- Determine changes in respondents’ attitudes and perceptions
- Assess the impact of inflation
- Capture physicians’ perception of Brexit
- The UK’s healthcare sector is facing greater negative impact from Brexit than other macro events.
- The result “reversal of the referendum” remained the best outcome of Brexit for the healthcare industry.
- Regulatory divergence is the healthcare sector’s main concern associated with the UK’s departure from the EU.
- The UK should reduce barriers to the UK-EU collaboration on clinical research to help its healthcare sector to thrive.
- Brexit impact on companies and their corporate strategies in the UK and across the EU continues to materialize.
- Departure from the EU exacerbated the challenges faced by the UK’s healthcare sector.
Reasons to Buy
- Develop and design your corporate strategies post-Brexit through an in-house expert analysis of the key factors to impact the post-Brexit UK healthcare industry.
- Develop business strategies by understanding the key factors to impact healthcare research and manufacturing in the UK post-Brexit.
- Stay up to date on the industry’s changing sentiment towards Brexit from within the healthcare industry.
- Identify emerging industry trends post-Brexit to gain a competitive advantage.
- Understand current macro events impacting healthcare industry in the UK post-Brexit.
International Monetary Fund
Organisation for Economic Cooperation and Development
Johnson & Johnson
British Medical Journal
Bank of England
Table of Contents
1. Study Design
2. Executive Summary
3. UK Pharma Industry and Brexit
4. Outcome of Brexit
5. Factors to Impact Healthcare
6. Impact on Research and Manufacturing
7. Impact on Corporate Strategy
8. Impact on the NHS
9. Brexit and Inflation
10. Future Prospects
11. Summary of Key Findings
13. Contact Us
Frequently asked questions
Which are the factors that will impact the UK’s healthcare industry post-Brexit?
Some of the significant factors which will impact the UK’s healthcare industry post-Brexit are Funding for research and manufacturing, Regulatory implications, Delayed access to new health technologies and therapies, and Delayed drug approval, among others.
Which are the initiatives that could help the UK’s healthcare industry to recover post-Brexit?
Some of the initiatives that could help the UK’s healthcare industry to recover post-Brexit are relaxing regulations around clinical trials, speeding up the approval process for medical devices and medicines, facilitating prescription process of low-risk medicines, extending the UK’s lead in personalized medicine, and investing in innovations in healthcare such as artificial intelligence, among others.
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.
Business Intelligence & Marketing Manager, SAL Heavy Lift
“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.
GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”
Market Analyst & Management, Liebherr-Werk
“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”
Head of Key Accounts, Saab AB
Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.
Marketing Intelligence Manager, Portugal Foods
Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.
Head of Customer Insight and Research, Standard Chartered
Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.
I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.
I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.
Head of Consumer Sensory Insights, Givaudan
“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.
Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”
Senior Account Manager, TSYS
GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise. The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.
I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.
One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.